$66.32 price target - Evolution Capital initiation of coverage, page-60

We are talking to everyone interested. It’s just that Edwards has the most to lose. I have no doubt in Wayne’s ability to extract maximum competitive tension.

I also think that Wayne’s attitude has changed a little regarding his tenure and he is reinvigorated by the potential of DurAVR. Sorting out the mess he inherited took its toll on him. Perhaps now he may see it through alone until we are bought. Being bought out is a fate accompli. Hopefully it’s way down the track. If we stay stand alone I will be amazed.

IMO - Not advice.